Our latest

Hyris expands testing rapid technology aimed at supporting the fight against malaria
Hyris’ molecular diagnostic technology will now enable in-field data to be gathered in real-time from up to 30 distributed locations in Cameroon.

Hyris signs a distribution agreement with GrowBIGogh
Hyris signed a distribution agreement with GrowBIGogh a a company selling technology solutions for hydroponics and farming industries, based in Gilroy & Salinas, CA.

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.
Climate change and global warming greatly boost viral outbreaks, as confirmed in a scientific study, highlighting the need for better pandemic readiness and disease surveillance.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.
A new international biotech group was born from the integration of Hyris Ltd, renowned worldwide for its disruptive genetic testing platform, and Ulisse Biomed S.p.A., also known as UBM Group or “UBM” only, a leading Italian-based publicly traded biotech company appreciated for its innovative testing platforms.